Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies by J Julien et al.
POSTER PRESENTATION Open Access
Recognition and penetration of the HIV-1 Env
glycan shield by potent broadly neutralizing
antibodies
J Julien8, L Kong8, R Pejchal8, R Khayat1, J Lee1, RS Stanfield8, LM Walker2, KJ Doores3, E Folkowska3, P Poignard2,
R Depetris4, RW Sanders5, WC Koff6, JP Moore4, AB Ward1, DR Burton7, IA Wilson8*
From AIDS Vaccine 2012
Boston, MA, USA. 9-12 September 2012
Background
Human monoclonal antibodies have been characterized
recently that potently neutralize HIV-1 isolates across
all clades. These exciting new antibodies (PGT series)
were derived from direct functional screening of B cells
from IAVI protocol G donors (Theraclone/Monogram)
and are unusually potent with binding predicted to be
to novel glycan-dependent epitopes on Env.
Methods
Structures of these new PGT antibodies are being deter-
mined by x-ray crystallography and electron microscopy
with further characterization using binding and muta-
genesis assays.
Results
The crystal and EM structures so far have been eluci-
dated for many of these antibodies. Work on the others
are in progress, focusing on Fab complexes with glycans,
gp120 core and fragment constructs, as well as Env
trimers.
Conclusion
Structural characterization and biochemical analysis of
these antibodies have uncovered novel specificities to
new glycan-dependent epitopes and reveal further
mechanisms for viral neutralization. These new epitopes
provide additional insights for neutralization of HIV-1
and how antibodies can bind and penetrate the glycan
shield, a novel framework for structure-assisted vaccine
design.
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